Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Pleural Neoplasms"" wg kryterium: Temat


Tytuł :
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial.
Autorzy :
Hiltbrunner S; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland.
Britschgi C; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland.
Schuberth P; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland.
Bankel L; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland.
Nguyen-Kim TDL; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Gulati P; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Weder W; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Opitz I; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Lauk O; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Caviezel C; Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Bachmann H; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland.
Tabor A; Biontech Innovative Manufacturing Services, Idar-Oberstein, Germany.
Schröder P; Biontech Innovative Manufacturing Services, Idar-Oberstein, Germany.
Knuth A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland.
Münz C; Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Stahel R; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Boyman O; Department of Immunology, University Hospital Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Renner C; Faculty of Medicine, University of Basel, Basel, Switzerland; Onkozentrum Zürich, Swiss Tumor Immunology Institute, Zurich, Switzerland.
Petrausch U; Faculty of Medicine, University of Zurich, Zurich, Switzerland; Onkozentrum Zürich, Swiss Tumor Immunology Institute, Zurich, Switzerland.
Curioni-Fontecedro A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Comprehensive Cancer Center Zurich, University of Zurich, Zurich, Switzerland; Faculty of Medicine, University of Zurich, Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Jan; Vol. 32 (1), pp. 120-121. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Lung Neoplasms*/drug therapy
Mesothelioma*/drug therapy
Mesothelioma, Malignant*
Pleural Neoplasms*/drug therapy
Fibroblasts ; Humans ; T-Lymphocytes
Raport
Tytuł :
Letter to the Editor: Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA.
Autorzy :
Lauer DJ 3rd; Cardno ChemRisk, 4940 Pearl East Circle Suite 100, Boulder, CO, 80301, USA. .
Mundt KA; Carndo ChemRisk, Boston, MA, USA.
Thompson WJ; Carndo ChemRisk, Boston, MA, USA.
Best EA; Cardno ChemRisk, 4940 Pearl East Circle Suite 100, Boulder, CO, 80301, USA.
Pokaż więcej
Źródło :
World journal of surgery [World J Surg] 2020 Dec; Vol. 44 (12), pp. 4279-4280. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Letter; Comment
MeSH Terms :
Lung Neoplasms*/epidemiology
Mesothelioma*/epidemiology
Mesothelioma, Malignant*
Pleural Neoplasms*/epidemiology
Humans ; Incidence ; United States/epidemiology
Opinia redakcyjna
Tytuł :
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.
Autorzy :
Kanellakis NI; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom .; Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Asciak R; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Hamid MA; Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Yao X; Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
McCole M; Cellular Pathology Department, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
McGowan S; Computational Biology Research Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Seraia E; Cellular High Throughput Screening Facility, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Hatch S; Cellular High Throughput Screening Facility, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Hallifax RJ; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Mercer RM; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Bedawi EO; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Jones S; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Verrill C; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Dobson M; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
George V; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Stathopoulos GT; Molecular Lung Carcinogenesis Group, Comprehensive Pneumology Center and Institute for Lung Biology and Disease, Ludwig-Maximilians University and Helmholtz Center, Munich, Germany.; Laboratory for Molecular Respiratory Carcinogenesis, Department of Physiology, Faculty of Medicine, University of Patras, Patras, Greece.
Peng Y; Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Ebner D; Cellular High Throughput Screening Facility, Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Dong T; Chinese Academy of Medical Sciences Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Rahman NM; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Psallidas I; Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Oxford Respiratory Trials Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło :
Thorax [Thorax] 2020 Nov; Vol. 75 (11), pp. 1004-1008. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*analysis
Mesothelioma, Malignant/*pathology
Pleural Neoplasms/*pathology
Tumor Cells, Cultured/*cytology
Cell Culture Techniques ; Genes, Tumor Suppressor ; High-Throughput Screening Assays ; Humans ; Immunotherapy ; Mesothelioma, Malignant/therapy ; Mutation ; Pleural Neoplasms/therapy ; Whole Genome Sequencing
Czasopismo naukowe
Tytuł :
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
Autorzy :
Nowak AK; Sir Charles Gairdner Hospital, Nedlands, WA, Australia; National Centre for Asbestos Related Diseases, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia. Electronic address: .
Lesterhuis WJ; National Centre for Asbestos Related Diseases, Perth, WA, Australia; School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia.
Kok PS; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
Brown C; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
Hughes BG; The Prince Charles Hospital and University of Queensland, Brisbane, QLD, Australia; University of Queensland, Brisbane, QLD, Australia.
Karikios DJ; Nepean Hospital, Kingswood, NSW, Australia.
John T; Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, VIC, Australia.
Kao SC; Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Leslie C; PathWest Laboratory Medicine, Nedlands, WA, Australia.
Cook AM; National Centre for Asbestos Related Diseases, Perth, WA, Australia; Medical School, University of Western Australia, Perth, WA, Australia.
Pavlakis N; Royal North Shore Hospital and Northern Cancer Institute, Sydney, NSW, Australia.
Briscoe K; Mid North Coast Cancer Institute, Coffs Harbour Health Campus, Coffs Harbour, NSW, Australia.
O'Byrne KJ; Princess Alexandra Hospital and Queensland University of Technology, Brisbane, QLD, Australia.
Karapetis CS; Flinders Medical Centre and Flinders University, Bedford Park, SA, Australia.
Lam WS; Department of Medical Oncology, Fiona Stanley Hospital and Western Australia Country Health Service, Perth, WA, Australia.
Langford A; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
Yip S; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
Stockler MR; National Health and Medical Research Council, Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Sep; Vol. 21 (9), pp. 1213-1223.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*administration & dosage
Cisplatin/*administration & dosage
Lung Neoplasms/*drug therapy
Mesothelioma/*drug therapy
Pemetrexed/*administration & dosage
Pleural Neoplasms/*drug therapy
Adolescent ; Adult ; Aged ; Antibodies, Anti-Idiotypic/administration & dosage ; Antibodies, Anti-Idiotypic/adverse effects ; Antibodies, Monoclonal/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Australia/epidemiology ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/genetics ; Cisplatin/adverse effects ; Female ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/immunology ; Lung Neoplasms/pathology ; Male ; Mesothelioma/genetics ; Mesothelioma/immunology ; Mesothelioma/pathology ; Mesothelioma, Malignant ; Middle Aged ; Pemetrexed/adverse effects ; Pleural Neoplasms/genetics ; Pleural Neoplasms/immunology ; Pleural Neoplasms/pathology ; Progression-Free Survival
Czasopismo naukowe
Tytuł :
Hypertrophic Pulmonary Osteoarthropathy Revealing a Solitary Fibrous Tumor.
Autorzy :
Auroux M; Hospices Civils de Lyon, Rheumatology, Lyon, Auvergne-Rhône-Alpes, France.
Adelaide L; Department of Clinical Immunology & Infectious Diseases, Centre Hospitalier de Vienne Lucien Hussel, Médecine interne, Montée du Dr Chapuis, Vienne, Rhône-Alpes, France. Electronic address: .
Pokaż więcej
Źródło :
Mayo Clinic proceedings [Mayo Clin Proc] 2020 Aug; Vol. 95 (8), pp. 1567-1568.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Osteoarthropathy, Secondary Hypertrophic/*diagnosis
Pleural Neoplasms/*diagnosis
Solitary Fibrous Tumors/*diagnosis
Female ; Humans ; Middle Aged ; Osteoarthropathy, Secondary Hypertrophic/complications ; Osteoarthropathy, Secondary Hypertrophic/diagnostic imaging ; Osteoarthropathy, Secondary Hypertrophic/pathology ; Pleural Neoplasms/complications ; Pleural Neoplasms/diagnostic imaging ; Pleural Neoplasms/pathology ; Radiography ; Solitary Fibrous Tumors/complications ; Solitary Fibrous Tumors/diagnostic imaging ; Solitary Fibrous Tumors/pathology ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France.
Autorzy :
Aarnink A; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, 21000, Dijon, France.
Fumet JD; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, 21000, Dijon, France.; Research Platform in Biological Oncology, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; University of Burgundy-Franche Comté, Dijon, France.; UMR INSERM 1231, Dijon, France.
Favier L; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, 21000, Dijon, France.
Truntzer C; Research Platform in Biological Oncology, Dijon, France.; GIMI Genetic and Immunology Medical Institute, Dijon, France.; UMR INSERM 1231, Dijon, France.
Ghiringhelli F; Department of Medical Oncology, Center Georges François Leclerc, 1 rue du Professeur Marion, 21000, Dijon, France. .; Research Platform in Biological Oncology, Dijon, France. .; GIMI Genetic and Immunology Medical Institute, Dijon, France. .; University of Burgundy-Franche Comté, Dijon, France. .; UMR INSERM 1231, Dijon, France. .
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Oct; Vol. 146 (10), pp. 2699-2707. Date of Electronic Publication: 2020 May 30.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Nivolumab/*therapeutic use
Peritoneal Neoplasms/*secondary
Pleural Neoplasms/*secondary
Adult ; Aged ; Aged, 80 and over ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/immunology ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/pathology ; Drug Resistance, Neoplasm ; Female ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms/immunology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Peritoneal Neoplasms/immunology ; Pleural Neoplasms/immunology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/immunology ; Progression-Free Survival ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Normal mesothelial cell lines newly derived from human pleural biopsy explants.
Autorzy :
Pruett N; Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Singh A; Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Shankar A; Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Schrump DS; Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Hoang CD; Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Pokaż więcej
Źródło :
American journal of physiology. Lung cellular and molecular physiology [Am J Physiol Lung Cell Mol Physiol] 2020 Oct 01; Vol. 319 (4), pp. L652-L660. Date of Electronic Publication: 2020 Jul 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms :
Epithelium/*pathology
Lung Neoplasms/*pathology
Mesothelioma/*pathology
Pleura/*pathology
Pleural Neoplasms/*pathology
Biopsy/methods ; Humans ; Mesothelioma, Malignant ; Pleural Neoplasms/metabolism ; Tumor Cells, Cultured ; Tumor Suppressor Proteins/metabolism ; Ubiquitin Thiolesterase/metabolism
Czasopismo naukowe
Tytuł :
[Clinical analysis of 30 cases with asbestos-related occupational tumors].
Autorzy :
Song PP; Qingdao Central Hospital, Qingdao 266042, China.
Sun XW; Qingdao Central Hospital, Qingdao 266042, China.
Zhang SQ; Qingdao Central Hospital, Qingdao 266042, China.
Gao Y; Qingdao Central Hospital, Qingdao 266042, China.
Zhang H; Qingdao Central Hospital, Qingdao 266042, China.
Chen YX; Qingdao Central Hospital, Qingdao 266042, China.
Pokaż więcej
Źródło :
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases [Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi] 2020 Sep 20; Vol. 38 (9), pp. 693-695.
Typ publikacji :
Journal Article
MeSH Terms :
Asbestos*/toxicity
Lung Neoplasms*/epidemiology
Mesothelioma*/chemically induced
Mesothelioma*/epidemiology
Occupational Diseases*/epidemiology
Occupational Exposure*/adverse effects
Pleural Neoplasms*
Humans ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Hyperthermic intraoperative intrapleural chemotherapy and surgical cytoreduction as part of multimodal treatment of malignant pleural mesothelioma - case report M. Szkorupa1, D. Klos1, J. Chudacek1, J. Hanuliak1, M. Stasek1, O. Fischer2, R. Lemstrova3.
Autorzy :
Chemotherapy HII
Report SCAPOMTOMPM
Szkorupa M
Klos D
Chudacek J
Hanuliak J
Stasek M
Fischer O
Lemstrová R
Pokaż więcej
Transliterated Title :
Hypertermická peroperační intrapleurální chemoterapie a chirurgická cytoredukce jako součást multimodální léčby maligního mezoteliomu pleury - kazuistika.
Źródło :
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti [Rozhl Chir] 2020 Fall; Vol. 99 (10), pp. 456-461.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Mesothelioma*/surgery
Pleural Neoplasms*/surgery
Cisplatin ; Combined Modality Therapy ; Cytoreduction Surgical Procedures ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Pneumonectomy
Czasopismo naukowe
Tytuł :
Evaluation of Nonresponse Bias in a Case-Control Study of Pleural Mesothelioma.
Autorzy :
Airoldi C; Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, CPO-Piedmont, 28100 Novara, Italy.
Ferrante D; Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, CPO-Piedmont, 28100 Novara, Italy.
Mirabelli D; Department of Medical Sciences, Unit of Cancer Epidemiology, CPO Piemonte and University of Turin, 10126 Turin, Italy.; Interdepartmental Centre G. Scansetti for Studies on Asbestos and other Toxic Particulates, University of Turin, 10125 Turin, Italy.
Azzolina D; Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, CPO-Piedmont, 28100 Novara, Italy.
Magnani C; Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, University of Eastern Piedmont, CPO-Piedmont, 28100 Novara, Italy.; Interdepartmental Centre G. Scansetti for Studies on Asbestos and other Toxic Particulates, University of Turin, 10125 Turin, Italy.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 Aug 24; Vol. 17 (17). Date of Electronic Publication: 2020 Aug 24.
Typ publikacji :
Journal Article
MeSH Terms :
Asbestos*
Mesothelioma*
Occupational Exposure*
Pleural Neoplasms*
Aged ; Aged, 80 and over ; Bias ; Case-Control Studies ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Using creative co-design to develop a decision support tool for people with malignant pleural effusion.
Autorzy :
Grindell C; CLAHRC YH, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, S10 2JF, UK. .
Tod A; School of Nursing and Midwifery, The University of Sheffield. Barber House Annex, 3a Clarkehouse Rd, Sheffield, S10 2LA, UK.
Bec R; Lab4living, Sheffield Hallam University, Cantor Building. Arundle Street, Sheffield, S1 2NU, UK.
Wolstenholme D; CLAHRC YH, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, S10 2JF, UK.
Bhatnagar R; Academic Respiratory Unit, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.
Sivakumar P; Department of Thoracic Medicine, St Thomas' Hospital, Guy's and St Thomas' NHS Trust, Westminster Bridge Road, London, SE1 7EH, UK.
Morley A; Academic Respiratory Unit, University of Bristol, Learning and Research Building, Southmead Hospital, Bristol, BS10 5NB, UK.
Holme J; Pleural Service, Whythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK.
Lyons J; Pleural Service, Whythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK.
Ahmed M; Pleural Service, Whythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK.
Jackson S; Pleural Service, Whythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK.
Wallace D; Department of Thoracic Medicine, St Thomas' Hospital, Guy's and St Thomas' NHS Trust, Westminster Bridge Road, London, SE1 7EH, UK.
Noorzad F; Department of Thoracic Medicine, St Thomas' Hospital, Guy's and St Thomas' NHS Trust, Westminster Bridge Road, London, SE1 7EH, UK.
Kamalanathan M; Department of Thoracic Medicine, St Thomas' Hospital, Guy's and St Thomas' NHS Trust, Westminster Bridge Road, London, SE1 7EH, UK.
Ahmed L; Department of Thoracic Medicine, St Thomas' Hospital, Guy's and St Thomas' NHS Trust, Westminster Bridge Road, London, SE1 7EH, UK.
Evison M; Pleural Service, Whythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK.
Pokaż więcej
Źródło :
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2020 Aug 05; Vol. 20 (1), pp. 179. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Breast Neoplasms*/pathology
Breast Neoplasms*/therapy
Decision Support Systems, Clinical*
Lung Neoplasms*/pathology
Lung Neoplasms*/therapy
Mesothelioma*/pathology
Mesothelioma*/therapy
Pleural Effusion, Malignant/*therapy
Pleural Neoplasms/*pathology
Decision Making ; Humans ; Pleural Effusion, Malignant/diagnosis ; Pleural Neoplasms/secondary
Czasopismo naukowe
Tytuł :
Heterologous sarcomatoid pleural mesothelioma with osteosarcomatous differentiation: a report of autopsy case that accomplished trimodality therapy and review of the literature.
Autorzy :
Itano H; Department of Thoracic Surgery, Uji Tokushu-kai Hospital, Uji, Japan. .; Department of Thoracic Surgery, Daiyu-kai General Hospital, 1-9-9 Sakura, Ichinomiya, 491-8558, Aichi, Japan. .
Takeda T; Department of Respiratory Medicine, Uji Tokushu-kai Hospital, Uji, Japan.
Yamada T; Department of Pathology, Uji Tokushu-kai Hospital, Uji, Japan.
Koide M; Department of Surgery, Uji Tokushu-kai Hospital, Uji, Japan.
Kobayashi T; Department of Surgery, Uji Tokushu-kai Hospital, Uji, Japan.
Pokaż więcej
Źródło :
General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2020 Aug; Vol. 68 (8), pp. 871-879. Date of Electronic Publication: 2019 Aug 01.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Mesothelioma/*surgery
Mesothelioma, Malignant/*surgery
Neoplasm Recurrence, Local/*surgery
Osteosarcoma/*surgery
Pleura/*pathology
Pleural Neoplasms/*surgery
Aged ; Asbestos/adverse effects ; Autopsy ; Biopsy ; Cell Differentiation ; Fatal Outcome ; Humans ; Lung/pathology ; Male ; Mesothelioma/chemically induced ; Mesothelioma/diagnostic imaging ; Neoplasm Recurrence, Local/mortality ; Pericardium/surgery ; Pleura/diagnostic imaging ; Pleural Neoplasms/diagnostic imaging ; Pneumonectomy ; Thoracic Wall/pathology
Czasopismo naukowe
Tytuł :
Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma.
Autorzy :
Hashimoto M; Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nisinohomiya, Hyogo, 6638501, Japan. .
Sato A; Department of Pathology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 6638501, Japan.
Kuroda A; Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nisinohomiya, Hyogo, 6638501, Japan.
Nakamura A; Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nisinohomiya, Hyogo, 6638501, Japan.
Nakamichi T; Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nisinohomiya, Hyogo, 6638501, Japan.
Kondo N; Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nisinohomiya, Hyogo, 6638501, Japan.
Yuki M; Department of Pathology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 6638501, Japan.
Nabeshima K; Department of Pathology, Fukuoka University Hospital and School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 8140180, Japan.
Tsujimura T; Department of Pathology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 6638501, Japan.
Hasegawa S; Department of Thoracic Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nisinohomiya, Hyogo, 6638501, Japan.
Pokaż więcej
Źródło :
General thoracic and cardiovascular surgery [Gen Thorac Cardiovasc Surg] 2020 Aug; Vol. 68 (8), pp. 820-827. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji :
Journal Article
MeSH Terms :
Biopsy/*methods
Lung Neoplasms/*diagnosis
Mesothelioma, Malignant/*diagnosis
Pleura/*pathology
Pleural Diseases/*diagnosis
Pleural Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Inflammation ; Lung Neoplasms/pathology ; Male ; Mesothelioma, Malignant/pathology ; Middle Aged ; Neoplasm Metastasis ; Pleural Diseases/pathology ; Pleural Neoplasms/pathology ; Retrospective Studies ; Thoracic Surgery, Video-Assisted
Czasopismo naukowe
Tytuł :
Case report: uniportal video-assisted thoracoscopic resection of a solitary fibrous tumor preoperatively predicted visceral pleura origin using dynamic chest radiography.
Autorzy :
Tamura M; Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi 13-1, Kanazawa, 920-8640, Japan. .
Matsumoto I; Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi 13-1, Kanazawa, 920-8640, Japan.
Saito D; Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi 13-1, Kanazawa, 920-8640, Japan.
Yoshida S; Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi 13-1, Kanazawa, 920-8640, Japan.
Takata M; Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi 13-1, Kanazawa, 920-8640, Japan.
Takemura H; Department of Thoracic, Cardiovascular and General Surgery, Kanazawa University, Takara-machi 13-1, Kanazawa, 920-8640, Japan.
Pokaż więcej
Źródło :
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2020 Jul 08; Vol. 15 (1), pp. 166. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Pleural Neoplasms/*surgery
Radiography, Thoracic/*methods
Solitary Fibrous Tumor, Pleural/*surgery
Thoracic Surgery, Video-Assisted/*methods
Female ; Humans ; Middle Aged ; Pleural Neoplasms/diagnostic imaging ; Pleural Neoplasms/pathology ; Pulmonary Ventilation ; Solitary Fibrous Tumor, Pleural/diagnostic imaging ; Solitary Fibrous Tumor, Pleural/pathology
Czasopismo naukowe
Tytuł :
Posterior Intercostal Lymph Nodes Double Recurrence and Death Risk in Malignant Pleural Mesothelioma.
Autorzy :
Friedberg JS; Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: .
Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Culligan MJ; Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Putt ME; Department of Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Barsky AR; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Katz S; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Cengel KA; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2020 Jul; Vol. 110 (1), pp. 241-250. Date of Electronic Publication: 2019 Oct 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Lung Neoplasms/*mortality
Lung Neoplasms/*pathology
Lymph Nodes/*pathology
Mesothelioma/*mortality
Mesothelioma/*pathology
Neoplasm Recurrence, Local/*epidemiology
Pleural Neoplasms/*mortality
Pleural Neoplasms/*pathology
Aged ; Female ; Humans ; Lung Neoplasms/surgery ; Lymph Node Excision ; Lymph Nodes/surgery ; Male ; Mediastinum ; Mesothelioma/surgery ; Mesothelioma, Malignant ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Pleural Neoplasms/surgery ; Survival Rate
Czasopismo naukowe
Tytuł :
Giant Pleural Tumor And Severe Hypoglycemia: Doege-Potter Syndrome In A Previously Healthy Female.
Autorzy :
Junqueira N; Serviço de Cirugía Cardiotorácica, Hospital Santa Maria, Lisboa, Portugal.
Caldeira J; Serviço de Cirugía Cardiotorácica, Hospital Santa Maria, Lisboa, Portugal.
Ferreira R; Serviço de Cirugía Cardiotorácica, Hospital Santa Maria, Lisboa, Portugal.
Costa F; Serviço de Anestesia, Hospital Santa Maria Hospital, Lisboa, Portugal.
Silva J; Serviço de Cirugía Cardiotorácica, Hospital Santa Maria, Lisboa, Portugal.
Monteiro T; Serviço de Anestesia, Hospital Santa Maria Hospital, Lisboa, Portugal.
Nobre Â; Serviço de Cirugía Cardiotorácica, Hospital Santa Maria, Lisboa, Portugal.
Pokaż więcej
Źródło :
Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular [Rev Port Cir Cardiotorac Vasc] 2020 Jul-Sep; Vol. 27 (3), pp. 223-226.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hypoglycemia*/etiology
Kidney Diseases*/congenital
Pleural Neoplasms*/complications
Pleural Neoplasms*/diagnostic imaging
Pleural Neoplasms*/surgery
Congenital Abnormalities ; Female ; Humans ; Kidney/abnormalities ; Middle Aged ; Neoplasm Recurrence, Local
SCR Disease Name :
Hereditary renal agenesis
Czasopismo naukowe
Tytuł :
Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Autorzy :
Nakajima Y; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Kuribayashi K; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.; Department of Thoracic Oncology, Hyogo College of Medicine, Nishinomiya, Japan.
Ishigaki H; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Tada A; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Negi Y; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Minami T; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Takahashi R; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Doi H; Department of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Kitajima K; Department of Radiology, Hyogo College of Medicine, Nishinomiya, Japan.
Yokoi T; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.; Department of Thoracic Oncology, Hyogo College of Medicine, Nishinomiya, Japan.
Kijima T; Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.; Department of Thoracic Oncology, Hyogo College of Medicine, Nishinomiya, Japan.
Pokaż więcej
Źródło :
Cancer investigation [Cancer Invest] 2020 Jul; Vol. 38 (6), pp. 356-364. Date of Electronic Publication: 2020 Jun 16.
Typ publikacji :
Journal Article
MeSH Terms :
Adenosine Deaminase/*genetics
Lung Neoplasms/*diagnosis
Mesothelioma/*diagnosis
Neoplasms/*diagnosis
Pleural Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Male ; Mesothelioma/diagnostic imaging ; Mesothelioma/genetics ; Mesothelioma/pathology ; Mesothelioma, Malignant ; Middle Aged ; Mycobacterium tuberculosis/isolation & purification ; Mycobacterium tuberculosis/pathogenicity ; Neoplasms/diagnostic imaging ; Neoplasms/genetics ; Neoplasms/pathology ; Pleural Effusion, Malignant/diagnosis ; Pleural Effusion, Malignant/diagnostic imaging ; Pleural Effusion, Malignant/genetics ; Pleural Effusion, Malignant/pathology ; Pleural Neoplasms/diagnostic imaging ; Pleural Neoplasms/genetics ; Pleural Neoplasms/pathology ; Thoracoscopy ; Tuberculosis, Pleural/diagnosis ; Tuberculosis, Pleural/genetics ; Tuberculosis, Pleural/microbiology ; Tuberculosis, Pleural/pathology
Czasopismo naukowe
Tytuł :
Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy.
Autorzy :
Torricelli F; Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Saxena A; UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, UK.
Nuamah R; UK NIHR GSTFT/KCL Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust, London, UK.
Neat M; Cancer Genetics, Viapath, Guy's Hospital, London, UK.
Harling L; Department of Surgery and Cancer, Imperial College London, UK.
Ng W; Department of Pathology, Guy's Hospital, London, UK.
Spicer J; Division of Cancer Studies, King's College London, Guy's Hospital, London, UK.
Ciarrocchi A; Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Bille A; Division of Cancer Studies, King's College London, Guy's Hospital, London, UK; Department of Thoracic Surgery, Guy's Hospital, London, UK. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Jun; Vol. 132, pp. 104-111. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Biomarkers, Tumor/*genetics
Gene Expression Regulation, Neoplastic/*drug effects
Genomics/*methods
Lung Neoplasms/*genetics
Mesothelioma/*genetics
Pleural Neoplasms/*genetics
Aged ; Electron Transport Complex III/genetics ; Female ; Follow-Up Studies ; Guanine Nucleotide Exchange Factors/genetics ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Male ; Mesothelioma/drug therapy ; Mesothelioma/pathology ; Mesothelioma, Malignant ; Palliative Care ; Pleural Neoplasms/drug therapy ; Pleural Neoplasms/pathology ; Prognosis ; Proteoglycans/genetics ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Preoperative prediction of unresectability in malignant pleural mesothelioma.
Autorzy :
Burt BM; Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex. Electronic address: .
Lee HS; Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
Raghuram AC; Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
Strange C; Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, Tex.
Mason J; Department of Radiology, Baylor College of Medicine, Houston, Tex.
Strange T; Department of Radiology, Baylor College of Medicine, Houston, Tex.
Delgado J; Department of Radiology, Baylor College of Medicine, Houston, Tex.
Sugarbaker DJ; Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
Pokaż więcej
Źródło :
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2020 Jun; Vol. 159 (6), pp. 2512-2520.e1. Date of Electronic Publication: 2019 Nov 27.
Typ publikacji :
Journal Article
MeSH Terms :
Tomography, X-Ray Computed*
Lung Neoplasms/*diagnostic imaging
Mesothelioma/*diagnostic imaging
Pleural Neoplasms/*diagnostic imaging
Thoracic Wall/*diagnostic imaging
Aged ; Aged, 80 and over ; Clinical Decision-Making ; Female ; Humans ; Imaging, Three-Dimensional ; Lung Neoplasms/pathology ; Lung Neoplasms/therapy ; Male ; Mesothelioma/pathology ; Mesothelioma/therapy ; Mesothelioma, Malignant ; Middle Aged ; Neoplasm Invasiveness ; Patient Selection ; Pleural Neoplasms/pathology ; Pleural Neoplasms/therapy ; Predictive Value of Tests ; Retrospective Studies ; Thoracic Wall/pathology ; Thoracic Wall/surgery ; Thoracotomy ; Unnecessary Procedures
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies